Alpha DNA Investment Management’s Salesforce CRM Stock Holding History
Bought
Maintained
Sold
Other funds holding CRM
Alpha DNA Investment Management's CRM Position: Q2 2023 in Review
Alpha DNA Investment Management sold out of Salesforce (CRM) in Q2 2023, closing a stake of 6,963 shares — an estimated $1.39M sold.
Alpha DNA Investment Management first reported a position in CRM in Q4 2020 and held it in 4 quarters. The position peaked at $1.74M in Q3 2021. 2,294 funds tracked by Wall St. Rank hold CRM as of Q2 2023.
- Alpha DNA Investment Management reported no remaining Salesforce position as of Q2 2023 after selling out during the quarter.
- Alpha DNA Investment Management sold 6,963 Salesforce shares in Q2 2023, an estimated $1.39M.
- Alpha DNA Investment Management first reported a position in Salesforce in Q4 2020 and held it in 4 quarters.
- Alpha DNA Investment Management's Salesforce position peaked at $1.74M in Q3 2021.
- 2,294 funds tracked by Wall St. Rank held Salesforce as of Q2 2023.
Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.